No influence of large volume blood loss on serum vancomycin concentrations during orthopedic procedures

Acta Orthopaedica Scandinavica

Volumn 70, Issue 1, 1999, Pages 47-50

  Klekamp, John W ^a,b   DiPersio, David ^a   Haas, David W ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; FLUID THERAPY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; OBESITY; ORTHOPEDIC SURGERY; PLASMA HALF LIFE; RESUSCITATION; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS;

EID: 0032983351     PISSN: 00016470     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679909000957     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention MMWR. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee 1994; 44 (RR-12): 1-12.
2. Cockcroft D W, Gault, M H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
3. Fitzgerald R H, Washinglon J A. Contamination of the operative wound. Orthop Clin North Am 1975; 6: 1105-14.
4. Guiboux J P, Cantor J B, Small S D. The effect of prophylactic antibiotics on iatrogenic intervertebral disc infections: A rabbit model. Spine 1995; 20: 685-8.
5. James P J, Butcher I A, Gardner E R. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg (Br) 1994; 76: 725-7.
6. Johnson K D, Johnston D W C. Orthopedic experience with methicillin-resistant Staphylococcus aureus during a hospital epidemic. Clin Orthop 1986; 212: 281-4.
7. Mader J T, Cierny G III. The principles of the use of preventive antibiotics. Clin Orthop 1984; 190: 75-82.
8. Maki D G, Bohn M J, Stolz S M. Comparative study of cefazolin, cefamandole and vancomycin for surgical prophylaxis in cardiac and vascular operations: A double-blind randomized trial. J Thorac Cardiovasc Surg 1992; 104: 1423-34.
9. Massias L, Dubois C, de Lentdecker P, Brodaty O:. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992; 36: 2539-41.
10. Meter J J, Polly D W, Bruekner R P, et al. Effect of intraoperative blood loss on the serum level of cefazolin in patients managed with total hip arthroplasty. J Bone Joint Surg (Am) 1996; 78 (8): 1201-5.
11. Polly D W, Meter J J Bruekner R, et al. The effect of intraoperative blood loss on serum cefazolin level in patients undergoing instrumented spinal fusion - A prospective, controlled study. Spine 1996; 21(20): 2363-7.
12. Ritter M A, Barzilauskas C D, Faris P M. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics 1989; 12: 1333-6.
13. Scuderi G J, Greenberg S S, Banovac K, Martinez O V. Eismont F J. Penetration of glycopeptide antibiotics in nucleus pulposus. Spine 1993; 18: 2039-42.